Investment Firm Adds Nearly $4 Million in DYN Shares
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Explore how diversified broad market strategies compare to target date funds for retirement. Learn key differences shaping risk, diversification, and long-term growth.
28,533 articlesA major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
Wealthy Americans are dialing back on flaunting jewelry as market mood shifts. The trend could signal changing demand...
A legendary macro investor who warned about the 2008 bubble has sold Alphabet and moved into AI hardware names, signa...
Ethereum briefly topped near $1,950 before stalling, with analysts cautioning that the worst still ahead could materi...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
Analysts clash over SpaceX's value as Oppenheimer targets a $250 price, while Michael Burry stays neutral. The debate...
Syndicate Labs, a16z-backed, is closing its development arm after five years of building on-chain tooling, blaming a ...
When a major chip stock slips, it sparks questions about why the move happened and what it means for your plan. This ...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
When an energy storage company reports stronger results, the market often reacts with a sharp stock move. This guide ...
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Explore dragonfly (dfli) 2026 earnings to understand growth drivers, margin discipline, and what the results imply fo...